SCHEMBL21165624

SCHEMBL21165624

c1ccc(-c2cccc(-n3c4ccc(-c5ccc(-c6ccc7c(c6)c6cc(-c8ccccc8)ccc6n7-c6cc(-c7ccccc7)ccc6-c6ccccc6)cc5)cc4c4c(-c5ccccc5)cccc43)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TSPO P30536 1/20 0.34
HTT P42858 2/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
PDE10A Q9Y233 1/20 0.33
FAAH O00519 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PKM P14618 1/20 0.33
MGLL Q99685 1/20 0.33
MAPK14 Q16539 1/20 0.33
ALK Q9UM73 2/20 0.32
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
MEN1 O00255 1/20 0.32
APAF1 O14727 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21165637 0.97 ATM (0.41) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165621 0.97 ATM (0.41) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165694 0.97 ALK (0.34) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165610 0.96 ATM (0.40) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165623 0.96 L3MBTL1 (0.40) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165587 0.95 ATM (0.39) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165596 0.95 ATM (0.39) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165574 0.95 ATM (0.39) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165625 0.95 ATM (0.36) ATML3MBTL1KDM4ETSPOHTT
SCHEMBL21165663 0.95 L3MBTL1 (0.41) ATML3MBTL1KDM4ETSPOHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190221750-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CRY1, CRY2, MCM4 ATM 1310/4885L3MBTL1 2041/4885KDM4E 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.